Skip to content
Menu

Adagio Medical Holdings, Inc. ADGM

Full chart Compare
Set alert

Price alert · ADGM

All alert types
1.95 USD +0.13 (+6.87%)

Nov 13, 2026, 2:01 PM EST

1.82 Day range 1.95
1.50 52-week range 50.70
YTD
-93.77%
1 year
-92.05%
Market cap
53.37M
Revenue (ttm)
399.00K
EPS (ttm)
-41.10
Shares out
14.54M
YTD return
-93.77%
1-year return
-92.05%
Volume
31.98K
Avg volume
90.22K
Open
1.82
Previous close
1.82
Day's range
1.82 – 1.95
52-week range
1.50 – 50.70
Beta
-0.10

5D -0.07 (-3.70%)

1.501.7522.25FriMonTueWedThu1.82

Key statistics

Enterprise value
139.84M
PEG ratio
0.00
Price / sales
35.35
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
109.90%
Free cash flow
0
Total cash
2.04M
Total debt
52.21M
Return on equity
0.00%
Short % of float
0.00%
50-day average
2.49
200-day average
3.40

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
ADGM Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ADGM Net income — quarterly -6.72M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ADGM EPS — quarterly -9.00
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

About Adagio Medical Holdings, Inc.

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company was founded in 2011 and is headquartered in Laguna Hills, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ADGM — it syncs with the Stock Master app.

Institution ownership

ADGM institution ownership
Holder% heldSharesValueReported
Perceptive Advisors Llc67.51%9,812,4199.52MSep 29, 2024
RA Capital Management, L.P.9.18%1,333,9261.29MSep 29, 2024
Affinity Asset Advisors, Llc1.47%213,235206.94KSep 29, 2024
RTW Investments LP1.44%209,361203.18KSep 29, 2024
Adar1 Capital Management, LLC 1.02%148,861144.47KSep 29, 2024
Shaolin Capital Management LLC0.96%140,000135.87KSep 29, 2024

Fund ownership

ADGM fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.08%12,28711.92KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.05%7,6097.38KOct 30, 2024
Fidelity Series Total Market Index Fund0.02%2,9362.85KOct 30, 2024